Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassandra Calabrese

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Clinical Genitourinary Cancer|March 3, 2019
Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint InhibitorsMoshe C Ornstein, Cassandra Calabrese, Laura S Wood, et al.
Cancers|June 22, 2023
Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative StudyMaria A Lopez-Olivo, Gabrielle F Duhon, Juan I Ruiz, et al.
JMIR Cancer|October 25, 2024
Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability StudyMaria A Lopez-Olivo, Maria E Suarez-Almazor, Gabrielle F Duhon, et al.
Cancers|August 12, 2023
Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint InhibitorsMaria A Lopez-Olivo, Johncy J Kachira, Maryam Buni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 17, 2021
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2022
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
ReplyJeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 8, 2022
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 15, 2021
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Clinical Genitourinary Cancer|March 3, 2019
Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint InhibitorsMoshe C Ornstein, Cassandra Calabrese, Laura S Wood, et al.
Cancers|June 22, 2023
Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative StudyMaria A Lopez-Olivo, Gabrielle F Duhon, Juan I Ruiz, et al.
JMIR Cancer|October 25, 2024
Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability StudyMaria A Lopez-Olivo, Maria E Suarez-Almazor, Gabrielle F Duhon, et al.
Cancers|August 12, 2023
Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint InhibitorsMaria A Lopez-Olivo, Johncy J Kachira, Maryam Buni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 17, 2021
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2022
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
ReplyJeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 8, 2022
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 15, 2021
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Pageof 7